Literature DB >> 24628336

High-risk human papillomavirus and lymph node size in patients with single node metastasis of oral and oropharyngeal cancer.

Young-Hoon Joo1, Kwang-Jae Cho, Jun-Ook Park, In-Chul Nam, Chung-Soo Kim, Min-Sik Kim.   

Abstract

CONCLUSION: High-risk human papillomavirus (HPV) infection was significantly related to lymph node size in patients with single node metastasis of oral and oropharyngeal cancer.
OBJECTIVE: The purpose of this study was to examine the relationship between high-risk HPV infection and lymph node size in patients with single node metastasis of oral and oropharyngeal carcinoma.
METHODS: This study included 48 patients with oral and oropharyngeal carcinoma. Pathologic lymph node stages comprised 36 N1 and 12 N2a.
RESULTS: High-risk HPV in situ hybridization was positive in 29% of patients (14/48). Of those patients with high-risk HPV, there was a significant difference (p = 0.008) between oral (9.5%) and oropharyngeal (44.4%) cancers. Average lymph node diameter was 20.7 ± 12.6 mm (range 5-54 mm). We found a positive correlation between high-risk HPV status and lymph node size (p = 0.018). Mean lymph node diameter in high-risk HPV-positive cases was 27.3 ± 13.1 mm and 18.0 ± 11.5 mm in high-risk HPV-negative cases. Extracapsular spread (p = 0.030) and cystic nodal metastases (p = 0.019) were also significantly related to lymph node size. High-risk HPV negative status (p = 0.043), advanced tumor stage (p = 0.009), and extracapsular spread (p = 0.038) all had significant adverse effects on 5-year disease-specific survival.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24628336     DOI: 10.3109/00016489.2013.844364

Source DB:  PubMed          Journal:  Acta Otolaryngol        ISSN: 0001-6489            Impact factor:   1.494


  5 in total

1.  Solid Lymph Nodes as an Imaging Biomarker for Risk Stratification in Human Papillomavirus-Related Oropharyngeal Squamous Cell Carcinoma.

Authors:  T J Rath; S Narayanan; M A Hughes; R L Ferris; S I Chiosea; B F Branstetter
Journal:  AJNR Am J Neuroradiol       Date:  2017-04-27       Impact factor: 3.825

2.  Predictors of Distant Metastasis after Radical Surgery Followed by Postoperative Radiotherapy with or without Chemotherapy for Oropharyngeal Cancer.

Authors:  Mi Joo Chung; Yeon Sil Kim; Ji Yoon Kim; Yun Hee Lee; Ji Hyun Jang; Jin Hyoung Kang; Ie Ryung Yoo; Youn Soo Lee
Journal:  Cancer Res Treat       Date:  2016-03-03       Impact factor: 4.679

3.  The Number of Radiographically Positive Lymph Nodes Further Stratifies Patient Survival Among Clinical N1 Patients With Human Papillomavirus-Associated Oropharyngeal Cancer.

Authors:  Roman O Kowalchuk; Kathryn M Van Abel; Adam B Sauer; Linda X Yin; Joaquin J Garcia; William S Harmsen; Eric J Moore; Daniel L Price; Ashish V Chintakuntlawar; Katharine R Price; Scott C Lester; Michelle Neben Wittich; Samir H Patel; Robert L Foote; Daniel M Ma; Alex A Nagelschneider; David M Routman
Journal:  Adv Radiat Oncol       Date:  2022-02-23

Review 4.  Advancements in the Management of HPV-Associated Head and Neck Squamous Cell Carcinoma.

Authors:  Ross Zeitlin; Harrison P Nguyen; David Rafferty; Stephen Tyring
Journal:  J Clin Med       Date:  2015-04-24       Impact factor: 4.241

5.  The rationale for HPV-related oropharyngeal cancer de-escalation treatment strategies.

Authors:  Małgorzata Wierzbicka; Krzysztof Szyfter; Piotr Milecki; Krzysztof Składowski; Rodryg Ramlau
Journal:  Contemp Oncol (Pozn)       Date:  2015-09-28
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.